Sign in
4

Changes in Ownership

Arbutus Biopharma Corp Filed Acc 0001567619-18-004380

Options or other derivatives

  • Director acquired 44,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

POTTER MYRTLE S · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-10-18 Grant or award : show line 1 in the form Director Share Option (Right to Buy) +44,000 44,000 D
Loading xslF345X03/doc1.xml…